Teligent Inc. (TLGT) Scheduled to Post Quarterly Earnings on Thursday
Teligent Inc. (NASDAQ:TLGT) will release its earnings data on Thursday, October 20th.
Teligent (NASDAQ:TLGT) last announced its quarterly earnings results on Thursday, July 28th. The company reported $0.02 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.02) by $0.04. The business earned $17.14 million during the quarter, compared to analyst estimates of $16.03 million. Teligent had a negative return on equity of 1.49% and a negative net margin of 22.81%. The firm’s revenue was up 92.8% on a year-over-year basis. During the same period in the previous year, the company earned ($0.05) EPS. On average, analysts expect Teligent to post $0.05 EPS for the current fiscal year and $0.15 EPS for the next fiscal year.
Shares of Teligent Inc. (NASDAQ:TLGT) opened at 7.23 on Wednesday. The firm’s market capitalization is $383.88 million. Teligent Inc. has a one year low of $4.46 and a one year high of $9.18. The stock’s 50 day moving average price is $7.62 and its 200 day moving average price is $6.93.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/19/teligent-inc-tlgt-scheduled-to-post-quarterly-earnings-on-thursday.html
Several large investors have recently made changes to their positions in the company. Elk Creek Partners LLC increased its stake in shares of Teligent by 12.8% in the second quarter. Elk Creek Partners LLC now owns 2,589,771 shares of the company’s stock valued at $18,491,000 after buying an additional 293,063 shares during the period. Guggenheim Capital LLC acquired a new stake in shares of Teligent during the second quarter valued at about $1,319,000. Allianz Asset Management AG increased its stake in shares of Teligent by 20.6% in the second quarter. Allianz Asset Management AG now owns 585,465 shares of the company’s stock valued at $4,180,000 after buying an additional 100,012 shares during the period. Janus Capital Management LLC increased its stake in shares of Teligent by 1.7% in the second quarter. Janus Capital Management LLC now owns 4,857,372 shares of the company’s stock valued at $34,682,000 after buying an additional 78,879 shares during the period. Finally, Vanguard Group Inc. increased its stake in shares of Teligent by 4.2% in the second quarter. Vanguard Group Inc. now owns 1,677,844 shares of the company’s stock valued at $11,980,000 after buying an additional 67,794 shares during the period. Institutional investors own 69.64% of the company’s stock.
TLGT has been the subject of a number of recent analyst reports. Raymond James Financial Inc. initiated coverage on Teligent in a report on Wednesday, June 22nd. They issued a “strong-buy” rating and a $11.00 price objective for the company. Zacks Investment Research upgraded Teligent from a “hold” rating to a “buy” rating and set a $9.25 price objective for the company in a report on Wednesday, July 27th. JMP Securities initiated coverage on Teligent in a report on Wednesday, June 29th. They issued a “hold” rating for the company. Finally, TheStreet upgraded Teligent from a “sell” rating to a “hold” rating in a report on Thursday, June 23rd. Four investment analysts have rated the stock with a hold rating, one has given a buy rating and one has given a strong buy rating to the company’s stock. Teligent has a consensus rating of “Buy” and an average price target of $9.25.
Teligent, Inc, formerly IGI Laboratories, Inc, is a specialty generic pharmaceutical company. The Company markets and sells generic injectable pharmaceutical products under its own label in the United States and Canada. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries.
Receive News & Ratings for Teligent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.